This study presents a valuable finding on the importance of the plasma metabolome in glaucoma risk prediction. The authors have used the UK Biobank data to interrogate the association between plasma ...

We are in the midst of a psychedelic renaissance,” writer guest author Pam Conboy. “Psilocybin, the active compound in ‘magic mushrooms,’ has demonstrated both a ...

The March of Dimes awarded a grant to further research into profiling the vaginal microbiome and investigate its connection ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

Studying drug-induced metabolic changes with high-throughput systems shed light on drug modes of action, providing an ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...

Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining ...

This article outlines the role of gut bacteria on mental health. This article outlines the positive benefit it is having.

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative ...

A streamlined synthesis of the psychoactive compound ibogaine could open up new opportunities in the treatment of drug ...

StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Ayala ...